Jason V. Coloma's most recent trade in Maze Therapeutics Inc. was a trade of 31,908 shares done at an average price of $27.0 . Disclosure was reported to the exchange on Oct. 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 27.02 per share. | 01 Oct 2026 | 31,908 | 191,447 | - | 27.0 | 862,186 | - |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 27.02 per share. | 01 Oct 2026 | 2,593 | 15,558 | - | 27.0 | 70,073 | - |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.01 per share. | 02 Sep 2026 | 11,282 | 27,491 | - | 26.0 | 293,482 | Common Stock |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.38 per share. | 02 Sep 2026 | 9,852 | 40,148 | - | 26.4 | 259,856 | Common Stock |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 27.12 per share. | 02 Sep 2026 | 1,375 | 38,773 | - | 27.1 | 37,292 | Common Stock |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 25.78 per share. | 02 Sep 2026 | 129 | 27,362 | - | 25.8 | 3,325 | Common Stock |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | 01 Sep 2026 | 50,000 | 50,000 | - | - | Restricted Stock Units | ||
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 50,000 | 50,000 | - | 0 | Common Stock | |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.29 per share. | 01 Sep 2026 | 31,908 | 223,355 | - | 26.3 | 838,785 | Common Stock |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.31 per share. | 01 Sep 2026 | 2,593 | 18,151 | - | 26.3 | 68,214 | Common Stock |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.71 per share. | 03 Aug 2026 | 30,304 | 256,867 | - | 26.7 | 809,541 | Common Stock |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.71 per share. | 03 Aug 2026 | 2,439 | 20,898 | - | 26.7 | 65,157 | Common Stock |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 27.09 per share. | 03 Aug 2026 | 1,604 | 255,263 | - | 27.1 | 43,445 | Common Stock |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 27.09 per share. | 03 Aug 2026 | 154 | 20,744 | - | 27.1 | 4,172 | Common Stock |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 29.95 per share. | 01 Jul 2026 | 30,311 | 288,768 | - | 30.0 | 907,921 | Common Stock |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 29.98 per share. | 01 Jul 2026 | 2,593 | 23,337 | - | 30.0 | 77,726 | Common Stock |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 30.44 per share. | 01 Jul 2026 | 1,597 | 287,171 | - | 30.4 | 48,606 | Common Stock |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.05 per share. | 22 Jun 2026 | 23,865 | 319,079 | - | 26.0 | 621,674 | Common Stock |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.00 per share. | 22 Jun 2026 | 2,040 | 25,930 | - | 26 | 53,040 | Common Stock |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.00 per share. | 22 Jun 2026 | 1,953 | 342,944 | - | 26.0 | 50,781 | Common Stock |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.20 per share. | 01 Jun 2026 | 6,090 | 344,897 | - | 26.2 | 159,537 | Common Stock |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.24 per share. | 01 Jun 2026 | 553 | 27,970 | - | 26.2 | 14,511 | Common Stock |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.02 per share. | 22 May 2026 | 25,582 | 350,987 | - | 26.0 | 665,516 | Common Stock |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.00 per share. | 22 May 2026 | 4,504 | 376,569 | - | 26 | 117,104 | Common Stock |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.00 per share. | 22 May 2026 | 2,478 | 28,523 | - | 26 | 64,428 | Common Stock |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.00 per share. | 15 May 2026 | 1,822 | 381,073 | - | 26 | 47,372 | Common Stock |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.00 per share. | 15 May 2026 | 116 | 31,001 | - | 26 | 3,016 | Common Stock |
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | 02 Mar 2026 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | ||
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | 02 Mar 2026 | 75,000 | 75,000 | - | - | Restricted Stock Units | ||
| Maze Therapeutics Inc | Dr. Jason V. Coloma, PhD | Director, Chief Executive Officer | 22 Sep 2025 | 100,000 | 100,000 | - | - | Restricted Stock Units |